3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine-Reference-Cited by-同舟云学术

3′Nucleotidase/nuclease is required for Leishmania infantum clinical isolate susceptibility to miltefosine

Published:2022-12 Issue: Volume:86 Page:104378
ISSN:2352-3964
Container-title:eBioMedicine
language:en
Short-container-title:eBioMedicine

Author:

Carnielli Juliana B.T.,Dave Anuja,Romano Audrey,Forrester Sarah,de Faria Pedro R.,Monti-Rocha Renata,Costa Carlos H.N.,Dietze Reynaldo,Graham Ian A.,Mottram Jeremy C.

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology,General Medicine

Reference66 articles.

1. Leishmaniasis;World Health Organization,2020

2. Proteasome inhibition for treatment of leishmaniasis, Chagas disease and sleeping sickness;Khare;Nature,2016

3. Preclinical candidate for the treatment of visceral leishmaniasis that acts through proteasome inhibition;Wyllie;Proc Natl Acad Sci USA,2019

4. Cyclin-dependent kinase 12 is a drug target for visceral leishmaniasis;Wyllie;Nature,2018

5. Drug discovery for kinetoplastid diseases: future directions;Rao;ACS Infect Dis,2019

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Gene deletion as a possible strategy adopted by New WorldLeishmania infantumto maximize geographic dispersion;2024-05-22

2. Protists: Eukaryotic single-celled organisms and the functioning of their organelles;Advances in Microbial Physiology;2024

3. Recent Advances in CRISPR/Cas9-Mediated Genome Editing in Leishmania Strains;Acta Parasitologica;2023-12-21

4. The status of combination therapy for visceral leishmaniasis: an updated review;The Lancet Infectious Diseases;2023-08

5. The use of imaging flow cytometry for rapid, high-throughput and automated analysis of theLeishmania mexicanapromastigote cell cycle provides new insights into cell cycle events of short duration;2023-07-25